ºÝºÝߣ

theheart.org cardiology aha 2010 acc 2011 esc 2011 aha 2011 tct 2011 tavi revascularization acs clopidogrel s yusuf slideshow presentation hrs 2011 research highlights fame ii theheart.org ppt diabetes myocardial infarction advance acute coronary syndrome enoxaparin cardiac resynchronization platelet inhibition altitude europcr 2011 protect-af partner cohort b slides atorvastatin sirolimus-eluting stent renal denervation everolimus-eluting stent partner cohort a statins warfarin ffr rivaroxaban acute myocardial infarction staccato xience v acc trial twente advance pdf advance study advance trial prasugrel trigger pci europcr 2012 ascert stampede cabg einstein pe romicat saturn tracer pallas power fast aim-high stable cad emphasis-hf trial emphasis-hf study emphasis-hf pdf heart attack type 2 diabetes heart disease angioplasty heart failure define simvastatin gravitas cardiovascular risk g stone tct 2007 m leon act coronary artery bare-metal stents crt raft aortic stenosis basket-prove closure i polyunsaturated fatty acids p-om3 acc 2008 spirit iv paclitaxel-eluting stents shift nyha acute mi stemi slideshow emphasis-hf aldosterone blockade rival platinum scientific sessions everest ii oscar magellan precombat isar cabg prelude discern-af acute ischemic syndromes base-acs fondaparinux discover flow anglo-scandinavian acc 2006 hypertension lvef compare ii af ablation placement of aortic transcatheter valve trial rocket af comfortable-ami stich coronary artery disease atrial fibrillation stroke heart rhythm society partner a clinical trial transcatheter aortic-valve implantation omt apixaban averroes partner cohort b ppt lipid lowering arm p sever ascot-lla chd coronary heart disease cetp inhibitor ascot-bpla noninvasive fractional flow reserve dalcetrpib t luscher dal-vessel endothelial function source scaar registry cost analysis severe aortic disease des meta-analysis jupiter slides enhance clopidogrel optimal s mehta current oasis-7 antiplatelet strategy esc 2009 nyha class 3-4 hf care-hf qrs apixaban versus acetylsalicylic acid to prevent st jgf cleland surgical treatment for ischemic heart failure f zannad perindopril studies macrovascular outcomes indapamide microvascular outcomes type 2 diabetes mellitus partner cohort b invasively measured fractional flow reserve stenoses ffrct bon-kwon koo jupiter ppt bridge advise (ffr) partner a (qol and efficacy) tct 2011 career achievement award rifle steacs partner b san francisco homburg cream & sugar study cv morbidity cv mortality glucose tolerance tg tolerance u laufs hcs mild hf esc medical congress esc cardiology news b pitt high-risk subgroups eplerenone esc cardiology conference xience v stent everolimus drug-eluting stent blood glucose bare-metal stent cobalt-chromium stent partner cohort b trial subcutaneous-lead icd vt ablation study efs confirm working with industry raft. rocket af ppt rocket ppt trial slides plato ppt aeds hrs/ehra consensus statement plato trial slides re-ly ppt re-ly trial slides averroes ppt partner cohort b cost analysis new orleans averroes trial slides stitch ppt stitch slides excellent. european society of cardiology esc paris resolute esc slides aggressive drug evaluation courage ticagrelor pci p karjalainen major adverse cardiovascular events thienopyridine mace bio-active-stent plato patient diaries implantable loop recorder platelet a verma c napolitano programmed electrical stimulation brugada syndrome icd implanted devices trial rosuvastatin shock therapy mortality b powell jupiter trial grafts thromboembolism aortic trial systolic heart partner cohort b aortic transcatheter valve trial sodium-potassium esc 2010 sinoatrial node ventricular dysfunction theheartorg ppt resynchronization reverses remodeling stroke prevention reverse c linde acc 2009 embolic protection dr holmes warfarin therapy probe c pepine acc 2003 international verapamil sr-trandolapril invest acc 2007 w e boden clinical outcomes non-valvular af a cohen inflammatory/rheumatic diseases ischemic stroke active cancer vte prophylaxis everest mitraclip vs surgery mitral regurgitation t feldman endovascular valve edge-to-edge repair accord lipid lipid-lowering arm h ginsberg blood lipids cardiovascular risk in diabetes randomized evaluation of long-term anticoagulant t extract–timi 25 thrombolysis low-molecular-weight heparin thrombolysis reperfusion myocardial infarction 25 heterozygous familial hypercholesterolemia atherosclerotic aspirin ezetimibe tct 2011 keynote address j mehilli drug-eluting stenting hc gwon xience v/promus oral anticoagulants excellent cypher select theheart ppt zotarolimus-eluting resolute ac p serruys resolute us warfarin alternative novo lesions promus element novo coronary artery lesions dabigatran platinum scaffolding venous thromboembolism sj park cabg surgery re-ly olmesartan calcium-channel blocker. h ogawa calcium antagonists raaft-2 ntiarrhythmic drug aad paroxysmal recurrent af catheter-based pulmonary vein isolation af irrigated unipolar rf ablation cure-af concomitant cardiac surgery biopolar rf ablation atrioventricular nodal cardioblate postoperative product transfusion transfusion guidelines blood-product use postoperative events cardiac operations. intraoperative product transfu ldl-c high-risk primary-prevention bp two doses of low-strength polycap low-strength polycap tips 2 physical-activity patterns cardiac rehabilitation program euraction strock vorapaxar thrombin receptor antagonist tra 2ºp-timi 50 hrs atherothrombotic ischemic atherosclesis computer assisted tomography ii raaft 2 symptomatic pulmonary embolism acute symptomatic pulmonary embolism symptomatic dvt oral rivaroxaban syncope of uncertain etiology pacemaker therapy systolic neurally mediated syncope issue-3 accf sts carlos morillo coronary disease vivek y reddy traditional care emergency department ccta acrin/pa tra 2°p – timi 50 mendelian rct live demonstrations prevent stroke acc 2012 c granger nobori biolimus-eluting stent everolimus eluting biolimus a9 eluting stent p smits biomatrix l räber gazelle in stemi biolimus-eluting stent acute st-elevation myocardial infarction total mortality left ventricular ejection fractions m gheorghiade heart failure congress 2012 clinical heart failure sinus rhythm digitalis investigation group digoxin dig systemic embolism aristotle partners surgical valve failure spouses diet pci plus omt ffr-guided simplicity htn 2 ethica award 2012 nhbli freee live demonstrations; compare ii; nobori biolimus s elevate adopt reimbursement source xt bioerodable polymer des aha 2011 s af c-port e martin leon atlas everolimus stents c-porte e acrin pa nobori biolimus stent coronary issue 3 steacs primary angioplasty radia fractional flow reserve adenosine vasodilator j davies debra doud raed abdelhadi riata thienopyridines ticlopidine d angiolillo coronary stents undergoing surgery cangrelor platelet reactivity d trenk firm ablation dan roden elective stent placement adverse cv coronary drug-eluting sents statin drug vitamin niacin cholesterol primary pci statin survey corp colchicine for recurrent pericarditis m imazio mvalgimigli dual antiplatelet therapy intimal hyperplasia prodigy drug-eluting-sent implantation fda aortic-valce replacement survery l thuesen valvular aortic stenosis memory loss endeavor resolute confusion icd lead safety target vessel failure drug-eluting stent c von birgelen nace st elevation transradial transfemoral femoral catheter ablation aceis free rx event economic evaluation beta blockers ahc 2011 t aversano c-port e cardiovascular patient outcomes research team elec open-heart surgery backup douglas zipes surgical ablation treatment atrial fibrillation catheter ablation lucas boersma af treatment lj appel wpw practice-based opportunities for weight reduction magnasafe obese people weight loss preventing mi preventing stroke vopaxar advanced medical therapy bariatric surgery starter w boden vascular events. m gibswon atlas acs 2 watchman laa closure device j mega elevate-timi 56 michel haÏŠssaguerre thrombolysis in mi 56 escalating clopidogrel cyp2c19 allele coronary atherosclerosis rosuvastatin intravascular ultrasound s nicholls coronary atheroma cv events permanent af sj connolly permanent atrial fibrillation dronedarone post-myocardial infarction n choudhry mi freee full perscription drug arbs ascot-lla study ascot-lla trial discover flow trial discover flow pdf discover flow study care-hf trial care-hf study care-hf pdf current oasis-7 trial current oasis-7 study current oasis-7 pdf enhance trial enhance pdf enhance study extract-timi 25 trial extract-timi 25 pdf extract-timi 25 study accord lipid trial accord lipid study accord lipid pdf everest study everest trial everest pdf magellan pdf magellan study magellan trial oscar trial oscar study oscar pdf precombat study precombat trial precombat pdf bridge trial thehert.org advise trial advise study advise pdf twente study twente trial twente pdf staccato trial staccato pdf staccato study prodigy trial prodigy pdf prodigy study corp pdf corp study corp trial examination trial examination study examination pdf hcs pdf hcs trial hcs study hcs theheart.org tct trial hrs trial europcr trial parreclose 2-acs dal-vessel pdf dal-vessel study dal-vessel trial ascot-lla pdf invest trial invest pdf protect-af pdf protect-af study protect-af trial spirit iv trial spirit iv pdf spirit iv study triton-timi 38 trial triton-timi 38 study triton-timi 38 pdf ascend-hf pdf ascend-hf trial ascend-hf study symplicity symplicity htn-2 trial symplicity htn-2 study symplicity htn-2 pdf p-om3 pdf p-om3 study p-om3 trial closure i trial closure i study closure i pdf basket-prove pdf basket-prove study basket-prove trial raft trial raft study raft pdf ascot-crp pdf ascot-crp study platinum trial platinum pdf platinum study resolute us study resolute ac trial resolute ac study resolute us trial excellent pdf excellent trial excellent study isar cabg trial isar cabg study isar cabg pdf altitude study altitude trial altitude pdf prelude trial prelude study prelude pdf discern-af trial. discern-af study discern-af pdf partner trial cohort a partner cohort a stroke data study partner cohort a stroke data trial base-acs study base-acs trial base-acs pdf courage pdf courage trial courage study pcsk9 poseidon / scipio phs ii trilogy acs/arctic umpire lodoco relax-ahf opera and forward thehear.org pcsk9 studies madit-rit aristotle study aristotle trial aristotle pdf dig pdf dig trial dig study comfortable-ami study comfortable-ami pdf comfortable-ami trial compare ii study compare ii trial compare ii pdf fame ii pdf fame ii trial fame ii study euraction pdf euraction trial euraction study tips 2 pdf tips 2 study tips 2 trial career achievement award adapt-des pfo closure live cases respect tct 2012 master trilogy-acs stemi-radial post ses partner b dessolve i and ii miami tavr pc trial munich trilogy acs gary. iabp shock ii woest esg 2012 the european society of cardiology defacto pure paramount esc 2012 congress access eu american heart association key trials aspire tact aha 2012 dal-outcomes tracer study power trial power pdf power study fast study fast trial fast pdf c-port e trial c-port e study c-port e pdf mi freee pdf mi freee trial mi freee study pallas trial pallas pdf pallas study saturn pdf saturn trial saturn study elevate-timi 56 pdf elevate-timi 56 study elevate-timi 56 trial atlas acs atlas acs 2 trial atlas acs 2 study atlas acs 2 pdf trigger pci trial trigger pci study trigger pci pdf bridge study bridge pdf invest study vcsqi pdf vcsqi study vcsqi trial cure-af pdf cure-af trial cure-af study raaft-2 study raaft-2 trial raaft-2 pdf acrin/pa pdf acrin/pa trial acrin/pa study ascert pdf ascert study ascert trial issue-3 trial issue-3 study issue-3 pdf einstein pe pdf einstein pe trial einstein pe study romicat ii trial romicat ii study romicat ii pdf tra 2ºp-timi 50 pdf tra 2ºp-timi 50 trial tra 2ºp-timi 50 study stampede trial stampede pdf stampede study tracer pdf residual platelet reactivity m price platelet-function tests thrombosis verifynow assay acc 2010 accord bp w c cushman blood–pressure-lowering arm glucose-lowering arm accord glucose synergy acc 2004 glycoprotein k mahaffey esc 2008 kk teo ace-intolerant high-risk diabetes transcend cardiovascular disease angiotensin-receptor blockers nyha class 2-3 g bardy scd-heft cardiac death amiodarone total cholesterol cp cannon prove-it pravastatin acc2004 endeavor zotarolimus taxus stents high-risk arterial fibrillation hrs 2008 sh hohnloser athena moderate risk arterial fibrillation chlothalidone antihypertensive lipid lowering treatment percutaneous revasculation acute catheterization and urgent intervention tria surgical revasculation high-risk acs gw stone prospective urban rural epidemiology chronic noncommunicable diseases societal influences cv risk factors left ventricular assist device mechanical assisted circulatory support interagency registry k d aaronsonm heartware thoratec's heartmate ii anacetrapib cetp cetp inhibition c cannon cholesteryl ester ldl-cholesterol bare-metal cobalt-chromium stent basel stent cost-effectiveness trial basket-late drug-eluting stents starflex septal closure patent foramen ovale paradoxical embolism transient ischemic attack a furlan omega-3 pufa pr kowey renal sympathetic md esler symplicity htn-2 uncontrolled hypertension clinical effectiveness decompensated heart failure nesiritide ascend-hf r califf s wiviott triton-timi 38 aha 2007 prasugrel-thrombolysis target lesion failure everolimus-eluting stents cad tct 2009 inhibitor ivabradine ivabradine m komajda stents in acute myocardial infarction horizons ami unfractionated heparin nyha class 2–4 omega-3 fatty acids miocardico–heart failure chronic heart failure statin therapy ²µ¾±²õ²õ¾±â€“h´Ú coronary intervention radial access s jolly acute coronary syndromes femoral access o berwanger antioxidant n-acetylcysteine acetylcysteine contrast-induced nephropathy c miller stroke data transcatheter aortic-valve aats 2011 c-reactive protein ascot-crp ps sever implantable cardioverter-defibrillator ambulatory heart failure moderate hf a tang resynchronization pharmacological therapy gravitas pdf pure study pure trial pure pdf acuity trial acuity study acuity pdf allhat study allhat trial allhat pdf hope pdf hope study hope trial athena trial athena pdf athena study acc research acc study ideal study ideal trial ideal pdf madit-crt study madit-crt trial oasis-5 study oasis-5 trial ontarget trial ontarget pdf ontarget study everest ii trial everest ii study edge-to-edge repair study everest ii pdf tracer trial ascot-crp trial partner cohort a trial elderly patients partner cohort a study partner cohort a pdf act trial act study act pdf rival study rival pdf rival trial horizons ami study horizons ami pdf horizons ami trial prove-it pdf prove-it trial prove-it study scd-heft trial scd-heft study scd-heft pdf synergy trial synergy study synergy pdf accord glucose trial accord glucose study accord glucose pdf accord bp trial accord bp pdf accord bp study gravitas trial gravitas study response futura oasis-8 alpha omega trial endovascular valve surgery mitraclip aha 2009 ³¦³ó²¹³¾±è¾±´Ç²Ôâ€Ë𳦾± ³¦³ó²¹³¾±è¾±´Ç²Ôâ€Ëð±ô²¹³Ù´Ú´Ç°ù³¾ d bhatt angiotensin ontarget ramipril global endpoint ongoing telmisartan receptor blocker oasis-5 factor-xa esc 2005 antithrombotic drugs oasis-6 safe antithrombotic agent ventricular dyssynchrony multicenter automatic defibrillator ideal lipid lowering t pedersen aha 2005 esc 1999 vascular disease heart outcomes prevention evaluation vessel revascularization c kaiser research esc esc trial tct pdf research tct research aha pdf champion trial ppt champion trial pdf champion study champion trial ascend hf symplicity htn ascot crp qrs emphasis-hf horizons-ami sort-out 4 partner compare cap isar-test 4 zilver ptx biofreedom tct 2010 robotically assisted pci copps lesson 1 cure/active a star-heart atoll einstein dvt innovate pci plato genetic substudies